Top

Published in:

28-09-2022 | Subarachnoid Hemorrhage | Research

The prognostic value of hyperglycemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

Authors: Min Shi, Ting-bao Zhang, Xiao-feng Li, Zong-yong Zhang, Ze-Jin Li, Xue-lou Wang, Wen-yuan Zhao

Published in: Neurosurgical Review | Issue 6/2022

Abstract

Recent studies have demonstrated that hyperglycemia may result in a poor prognosis following aneurysmal subarachnoid hemorrhage (aSAH). However, the association between hyperglycemia and the clinical outcome of aSAH has not been clearly established thus far. Therefore, we performed a systematic review and meta-analysis to investigate the association between hyperglycemia and the development of aSAH. We completed a literature search in four databases (PubMed, EMBASE, Cochrane Library, and Web of Science) up to November 1, 2021, including all eligible studies investigating the prognostic value of hyperglycemia in patients with aSAH. We performed a quality assessment of included studies using the Newcastle–Ottawa Quality Assessment Scale. The pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated to assess the association of hyperglycemia in aneurysmal subarachnoid hemorrhage. A total of 35 studies with 11,519 patients were finally included in the meta-analysis. Nineteen studies reported the association between hyperglycemia and poor outcome, 12 studies reported the association between hyperglycemia and all-cause mortality, 7 studies reported the association between hyperglycemia and cerebral vasospasm, and 9 studies reported the association between hyperglycemia and cerebral infarction. The pooled data of these studies suggested that hyperglycemia was significantly associated with poor functional outcomes (odds ratio [OR], 1.29; 95% confidence interval [CI], 1.17–1.42; P < 0.00001; I² = 83%), all-cause mortality (OR, 1.02; 95% CI, 1.01–1.04; P = 0.0006; I² = 89%), cerebral vasospasm (OR, 1.02; 95% CI, 1.01–1.02; P = 0.0002; I² = 35%), and cerebral infarction (OR, 1.16; 95% CI, 1.09–1.23; P < 0.00001; I² = 10%) in aSAH patients. These findings suggested that assessing for hyperglycemia at admission may help clinicians to identify critically ill patients and complete patient stratification early, which may achieve better management and improve the prognosis of patients with aSAH.

Available only for authorised users

Macdonald RL, Schweizer TA (2017) Spontaneous subarachnoid haemorrhage. Lancet 389(10069):655–666. https://doi.org/10.1016/s0140-6736(16)30668-7CrossRefPubMed

Rouanet C, Silva GS (2019) Aneurysmal subarachnoid hemorrhage: current concepts and updates. Arq Neuropsiquiatr 77(11):806–814. https://doi.org/10.1590/0004-282x20190112CrossRefPubMed

Walter J, Grutza M, Vogt L, Unterberg A, Zweckberger K (2020) The neuropsychological assessment battery (NAB) is a valuable tool for evaluating neuropsychological outcome after aneurysmatic subarachnoid hemorrhage. BMC Neurol 20(1):429. https://doi.org/10.1186/s12883-020-02003-9CrossRefPubMedPubMedCentral

Marder CP, Narla V, Fink JR, Tozer Fink KR (2014) Subarachnoid hemorrhage: beyond aneurysms. AJR Am J Roentgenol 202(1):25–37. https://doi.org/10.2214/ajr.12.9749CrossRefPubMed

Schupper AJ, Eagles ME, Neifert SN, Mocco J, Macdonald RL (2020) Lessons from the CONSCIOUS-1 Study. J Clin Med 9(9). https://doi.org/10.3390/jcm9092970.

Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8(7):635–642. https://doi.org/10.1016/s1474-4422(09)70126-7CrossRefPubMed

Neifert SN, Chapman EK, Martini ML, Shuman WH, Schupper AJ, Oermann EK et al (2021) Aneurysmal subarachnoid hemorrhage: the last decade. Transl Stroke Res 12(3):428–446. https://doi.org/10.1007/s12975-020-00867-0CrossRefPubMed

Thiele RH, Pouratian N, Zuo Z, Scalzo DC, Dobbs HA, Dumont AS et al (2009) Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology 110(3):603–610. https://doi.org/10.1097/ALN.0b013e318198006aCrossRefPubMed

Mahta A, Murray K, Reznik ME, Thompson BB, Wendell LC, Furie KL (2021) Early Neurological changes and interpretation of clinical grades in aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 30(9):105939. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105939CrossRefPubMed

10.

Rosen DS, Macdonald RL (2005) Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care 2(2):110–118. https://doi.org/10.1385/ncc:2:2:110CrossRefPubMed

11.

Fujiki Y, Matano F, Mizunari T, Murai Y, Tateyama K, Koketsu K et al (2018) Serum glucose/potassium ratio as a clinical risk factor for aneurysmal subarachnoid hemorrhage. J Neurosurg 129(4):870–875. https://doi.org/10.3171/2017.5.Jns162799CrossRefPubMed

12.

Pappacena S, Bailey M, Cabrini L, Landoni G, Udy A, Pilcher DV, et al (2019) Early dysglycemia and mortality in traumatic brain injury and subarachnoid hemorrhage. Minerva Anestesiol 85(8):830–9. https://doi.org/10.23736/s0375-9393.19.13307-x.

13.

Kruyt ND, Biessels GJ, de Haan RJ, Vermeulen M, Rinkel GJ, Coert B et al (2009) Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 40(6):e424–e430. https://doi.org/10.1161/strokeaha.108.529974CrossRefPubMed

14.

Guo X, Li H, Zhang Z, Li S, Zhang L, Zhang J et al (2016) Hyperglycemia and mortality risk in patients with primary intracerebral hemorrhage: a meta-analysis. Mol Neurobiol 53(4):2269–2275. https://doi.org/10.1007/s12035-015-9184-4CrossRefPubMed

15.

Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G (2013) European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 35(2):93–112. https://doi.org/10.1159/000346087CrossRefPubMed

16.

Kruyt ND, Biessels GJ, DeVries JH, Luitse MJ, Vermeulen M, Rinkel GJ et al (2010) Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome. J Cereb Blood Flow Metab 30(9):1577–1587. https://doi.org/10.1038/jcbfm.2010.102CrossRefPubMedPubMedCentral

17.

Mijiti M, Mijiti P, Axier A, Amuti M, Guohua Z, Xiaojiang C et al (2016) Incidence and predictors of angiographic vasospasm, symptomatic vasospasm and cerebral infarction in chinese patients with aneurysmal subarachnoid hemorrhage. PLoS ONE 11(12):e0168657. https://doi.org/10.1371/journal.pone.0168657CrossRefPubMedPubMedCentral

18.

Park CW, Yi HJ, Lee DH, Sung JH (2021) Association between HbA1C (glycated hemoglobin) and clinical outcomes in patients with subarachnoid hemorrhage after neuro-intervention. Curr Neurovasc Res 18(1):93–101. https://doi.org/10.2174/1567202618666210225103057CrossRefPubMed

19.

McIntyre MK, Halabi M, Li B, Long A, Van Hoof A, Afridi A et al (2021) Glycemic indices predict outcomes after aneurysmal subarachnoid hemorrhage: a retrospective single center comparative analysis. Sci Rep 11(1):158. https://doi.org/10.1038/s41598-020-80513-9CrossRefPubMedPubMedCentral

20.

Jung HM, Paik JH, Kim SY, Hong DY (2021) Association of plasma glucose to potassium ratio and mortality after aneurysmal subarachnoid hemorrhage. Front Neurol 12:661689. https://doi.org/10.3389/fneur.2021.661689CrossRefPubMedPubMedCentral

21.

Ndieugnou Djangang N, Ramunno P, Izzi A, Garufi A, Menozzi M, Diaferia D, et al (2020) The prognostic role of lactate concentrations after aneurysmal subarachnoid hemorrhage. Brain Sci 10(12). https://doi.org/10.3390/brainsci10121004.

22.

Zhang D, Yan H, Wei Y, Liu X, Zhuang Z, Dai W et al (2019) C-Reactive protein/albumin ratio correlates with disease severity and predicts outcome in patients with aneurysmal subarachnoid hemorrhage. Front Neurol 10:1186. https://doi.org/10.3389/fneur.2019.01186CrossRefPubMedPubMedCentral

23.

Oh CH, Kim JW, Kim GH, Lee KR, Hong DY, Park SO et al (2020) Serum lactate could predict mortality in patients with spontaneous subarachnoid hemorrhage in the emergency department. Front Neurol 11:975. https://doi.org/10.3389/fneur.2020.00975CrossRefPubMedPubMedCentral

24.

Doerfler S, Faerber J, McKhann GM, Elliott JP, Winn HR, Kumar M et al (2018) The incidence and impact of secondary cerebral insults on outcome after aneurysmal subarachnoid hemorrhage. World Neurosurg 114:e483–e494. https://doi.org/10.1016/j.wneu.2018.02.195CrossRefPubMed

25.

Zhang D, Zhuang Z, Wei Y, Liu X, Li W, Gao Y et al (2019) Association of admission serum glucose-phosphate ratio with severity and prognosis of aneurysmal subarachnoid hemorrhage. World Neurosurg 127:e1145–e1151. https://doi.org/10.1016/j.wneu.2019.04.071CrossRefPubMed

26.

Beseoglu K, Steiger HJ (2017) Elevated glycated hemoglobin level and hyperglycemia after aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 163:128–132. https://doi.org/10.1016/j.clineuro.2017.10.037CrossRefPubMed

27.

Rivero Rodríguez D, Scherle Matamoros C, Fernández Cúe L, Miranda Hernández JL, Pernas Sánchez Y, Pérez NJ (2017) Factors associated with poor outcome for aneurysmal subarachnoid haemorrhage in a series of 334 patients. Neurologia 32(1):15–21. https://doi.org/10.1016/j.nrl.2014.12.006CrossRefPubMed

28.

van Donkelaar CE, Dijkland SA, van den Bergh WM, Bakker J, Dippel DW, Nijsten MW et al (2016) Early circulating lactate and glucose levels after aneurysmal subarachnoid hemorrhage correlate with poor outcome and delayed cerebral ischemia: a two-center cohort study. Crit Care Med 44(5):966–972. https://doi.org/10.1097/ccm.0000000000001569CrossRefPubMed

29.

Turner CL, Budohoski K, Smith C, Hutchinson PJ, Kirkpatrick PJ, Murray GD (2015) Elevated baseline C-reactive protein as a predictor of outcome after aneurysmal subarachnoid hemorrhage: data from the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial. Neurosurgery 77(5):786–92; discussion 92–3. https://doi.org/10.1227/neu.0000000000000963.

30.

Inagawa T, Yahara K, Ohbayashi N (2014) Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 54(6):465–473. https://doi.org/10.2176/nmc.oa.2013-0169CrossRef

31.

Bian L, Liu L, Wang C, Hussain M, Yuan Y, Liu G et al (2013) Hyperglycemia within day 14 of aneurysmal subarachnoid hemorrhage predicts 1-year mortality. Clin Neurol Neurosurg 115(7):959–964. https://doi.org/10.1016/j.clineuro.2012.09.026CrossRefPubMed

32.

Fu C, Yu W, Sun L, Li D, Zhao C (2013) Early cerebral infarction following aneurysmal subarachnoid hemorrhage: frequency, risk factors, patterns, and prognosis. Curr Neurovasc Res 10(4):316–324. https://doi.org/10.2174/15672026113109990027CrossRefPubMed

33.

Ghosh S, Dey S, Maltenfort M, Vibbert M, Urtecho J, Rincon F et al (2012) Impact of Hunt-Hess grade on the glycemic status of aneurysmal subarachnoid hemorrhage patients. Neurol India 60(3):283–287. https://doi.org/10.4103/0028-3886.98510CrossRefPubMed

34.

Juvela S, Siironen J (2012) Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. Eur J Neurol 19(2):332–339. https://doi.org/10.1111/j.1468-1331.2011.03523.xCrossRefPubMed

35.

Zhang G, Zhang JH, Qin X (2011) Fever increased in-hospital mortality after subarachnoid hemorrhage. Acta Neurochir Suppl 110(Pt 1):239–243. https://doi.org/10.1007/978-3-7091-0353-1_42CrossRefPubMed

36.

Dumont T, Rughani A, Silver J, Tranmer BI (2009) Diabetes mellitus increases risk of vasospasm following aneurysmal subarachnoid hemorrhage independent of glycemic control. Neurocrit Care 11(2):183–189. https://doi.org/10.1007/s12028-009-9232-xCrossRefPubMed

37.

Kruyt ND, Roos YW, Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ et al (2008) High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 79(12):1382–1385. https://doi.org/10.1136/jnnp.2007.142034CrossRefPubMed

38.

Siironen J, Porras M, Varis J, Poussa K, Hernesniemi J, Juvela S (2007) Early ischemic lesion on computed tomography: predictor of poor outcome among survivors of aneurysmal subarachnoid hemorrhage. J Neurosurg 107(6):1074–1079. https://doi.org/10.3171/jns-07/12/1074CrossRefPubMed

39.

Frontera JA, Fernandez A, Claassen J, Schmidt M, Schumacher HC, Wartenberg K et al (2006) Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 37(1):199–203. https://doi.org/10.1161/01.STR.0000194960.73883.0fCrossRefPubMed

40.

McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE (2007) Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 107(6):1080–1085. https://doi.org/10.3171/jns-07/12/1080CrossRefPubMed

41.

Juvela S, Siironen J, Kuhmonen J (2005) Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 102(6):998–1003. https://doi.org/10.3171/jns.2005.102.6.0998CrossRefPubMed

42.

Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, et al (2005) Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 33(7):1603–9; quiz 23. https://doi.org/10.1097/01.ccm.0000168054.60538.2b.

43.

Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N et al (2004) Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med 32(3):832–838. https://doi.org/10.1097/01.ccm.0000114830.48833.8aCrossRefPubMed

44.

Dorhout Mees SM, van Dijk GW, Algra A, Kempink DR, Rinkel GJ (2003) Glucose levels and outcome after subarachnoid hemorrhage. Neurology 61(8):1132–1133. https://doi.org/10.1212/01.wnl.0000090466.68866.02CrossRefPubMed

45.

Alberti O, Becker R, Benes L, Wallenfang T, Bertalanffy H (2000) Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg 102(2):78–83. https://doi.org/10.1016/s0303-8467(00)00067-6CrossRefPubMed

46.

Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S et al (1999) Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 30(7):1402–1408. https://doi.org/10.1161/01.str.30.7.1402CrossRefPubMed

47.

Rivero Rodríguez D, Scherle Matamoros C, Cúe LF, Miranda Hernández JL, Pernas Sánchez Y, Pérez NJ (2015) Predictor's of mortality in patients with aneurysmal subarachnoid haemorrhage and reebleding. Neurol Res Int 2015:545407. https://doi.org/10.1155/2015/545407CrossRefPubMedPubMedCentral

48.

de Rooij NK, Greving JP, Rinkel GJ, Frijns CJ (2013) Early prediction of delayed cerebral ischemia after subarachnoid hemorrhage: development and validation of a practical risk chart. Stroke 44(5):1288–1294. https://doi.org/10.1161/strokeaha.113.001125CrossRefPubMed

49.

Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, et al (2006) Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 34(3):617–23; quiz 24. https://doi.org/10.1097/01.ccm.0000201903.46435.35.

50.

Mocco J, Ransom ER, Komotar RJ, Schmidt JM, Sciacca RR, Mayer SA, et al (2006) Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage. Neurosurgery 59(3):529–38; discussion -38. https://doi.org/10.1227/01.Neu.0000228680.22550.A2.

51.

de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ (2013) Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke 44(1):43–54. https://doi.org/10.1161/strokeaha.112.674291CrossRefPubMed

52.

Kurtz P, Claassen J, Schmidt JM, Helbok R, Hanafy KA, Presciutti M et al (2013) Reduced brain/serum glucose ratios predict cerebral metabolic distress and mortality after severe brain injury. Neurocrit Care 19(3):311–319. https://doi.org/10.1007/s12028-013-9919-xCrossRefPubMed

53.

Lanzino G, Kassell NF, Germanson T, Truskowski L, Alves W (1993) Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 79(6):885–891. https://doi.org/10.3171/jns.1993.79.6.0885CrossRefPubMed

54.

Ray B, Ludwig A, Yearout LK, Thompson DM, Bohnstedt BN (2017) Stress-induced hyperglycemia after spontaneous subarachnoid hemorrhage and its role in predicting cerebrospinal fluid diversion. World Neurosurg 100:208–215. https://doi.org/10.1016/j.wneu.2017.01.008CrossRefPubMed

55.

Vergouwen MD, van Geloven N, de Haan RJ, Kruyt ND, Vermeulen M, Roos YB (2010) Increased cortisol levels are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurocrit Care 12(3):342–345. https://doi.org/10.1007/s12028-010-9331-8CrossRefPubMed

56.

Ois A, Vivas E, Figueras-Aguirre G, Guimaraens L, Cuadrado-Godia E, Avellaneda C et al (2019) Misdiagnosis worsens prognosis in subarachnoid hemorrhage with good hunt and Hess score. Stroke 50(11):3072–3076. https://doi.org/10.1161/strokeaha.119.025520CrossRefPubMed

57.

Matano F, Fujiki Y, Mizunari T, Koketsu K, Tamaki T, Murai Y et al (2019) Serum glucose and potassium ratio as risk factors for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 28(7):1951–1957. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.03.041CrossRefPubMed

58.

Kurtz P, Claassen J, Helbok R, Schmidt J, Fernandez L, Presciutti M et al (2014) Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study. Crit Care 18(3):R89. https://doi.org/10.1186/cc13857CrossRefPubMedPubMedCentral

59.

Huang YH, Chung CL, Tsai HP, Wu SC, Chang CZ, Chai CY et al (2017) Hyperglycemia aggravates cerebral vasospasm after subarachnoid hemorrhage in a rat model. Neurosurgery 80(5):809–815. https://doi.org/10.1093/neuros/nyx016CrossRefPubMed

60.

Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M (2000) Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry 68(3):337–341. https://doi.org/10.1136/jnnp.68.3.337CrossRefPubMedPubMedCentral

61.

Ferguson S, Macdonald RL (2007) Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60(4):658–67; discussion 67. https://doi.org/10.1227/01.Neu.0000255396.23280.31.

62.

Fleming I, Busse R (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284(1):R1-12. https://doi.org/10.1152/ajpregu.00323.2002CrossRefPubMed

63.

Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA (2002) Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90(1):107–111. https://doi.org/10.1161/hh0102.102359CrossRefPubMed

64.

van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367. https://doi.org/10.1056/NEJMoa011300CrossRefPubMed

65.

Naidech AM, Levasseur K, Liebling S, Garg RK, Shapiro M, Ault ML et al (2010) Moderate hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage. Neurocrit Care 12(2):181–187. https://doi.org/10.1007/s12028-009-9311-zCrossRefPubMed

Title: The prognostic value of hyperglycemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis
Authors: Min Shi
Ting-bao Zhang
Xiao-feng Li
Zong-yong Zhang
Ze-Jin Li
Xue-lou Wang
Wen-yuan Zhao
Publication date: 28-09-2022
Publisher: Springer Berlin Heidelberg
Keywords: Subarachnoid Hemorrhage
Subarachnoid Hemorrhage
Hyperglycemia
Published in: Neurosurgical Review / Issue 6/2022
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI: https://doi.org/10.1007/s10143-022-01870-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The prognostic value of hyperglycemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2022

Current status and outlook of potential applications of biodegradable materials in cerebral vascular stents

Evaluating pituitary adenomas using national research databases: systematic review of the quality of reporting based on the STROBE scale

Intraoperative radiotherapy during awake craniotomies: preliminary results of a single-center case series

Combined application of neural stem/progenitor cells and scaffolds on locomotion recovery following spinal cord injury in rodents: a systematic review and meta-analysis

Surgical management outcomes of intracranial arteriovenous malformations after preoperative embolization: a systematic review and meta-analysis

Temporal muscle thickness as an independent prognostic marker in glioblastoma patients—a systematic review and meta-analysis